Literature DB >> 21053156

Nonclinical and clinical experiences with CPP-based self-assembling peptide systems in topical drug development.

Jacob M Waugh1, Jane Lee, Michael D Dake, Dan Browne.   

Abstract

Considerations in rational designs of CPP-based transcutaneous delivery systems are described. Impact of design considerations of nonclinical and clinical results are presented in detail.

Mesh：

Substances：

Year:  2011        PMID： 21053156     DOI： 10.1007/978-1-60761-919-2_39

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  3 in total

Review 1.  Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery.

Authors:  Helerin Margus; Kärt Padari; Margus Pooga
Journal:  Mol Ther       Date:  2012-01-10       Impact factor: 11.454

2.  Discovery and characterization of a new cell-penetrating protein.

Authors:  Rudo L Simeon; Ana Maria Chamoun; Thomas McMillin; Zhilei Chen
Journal:  ACS Chem Biol       Date:  2013-10-07       Impact factor: 5.100

Review 3.  The Expanding Therapeutic Utility of Botulinum Neurotoxins.

Authors:  Elena Fonfria; Jacquie Maignel; Stephane Lezmi; Vincent Martin; Andrew Splevins; Saif Shubber; Mikhail Kalinichev; Keith Foster; Philippe Picaut; Johannes Krupp
Journal:  Toxins (Basel)       Date:  2018-05-18       Impact factor: 4.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.